{"id":"https://openalex.org/W4389259284","doi":"https://doi.org/10.1182/blood-2023-187814","title":"Tuning the Innate Immune Multiple Myeloma Microenvironment By Modulating IRF4","display_name":"Tuning the Innate Immune Multiple Myeloma Microenvironment By Modulating IRF4","publication_year":2023,"publication_date":"2023-11-02","ids":{"openalex":"https://openalex.org/W4389259284","doi":"https://doi.org/10.1182/blood-2023-187814"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2023-187814","doi":"https://doi.org/10.1182/blood-2023-187814","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2023-187814","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027112699","display_name":"Silvia Vicenzi","orcid":"https://orcid.org/0000-0001-5670-7169","observed_orcids":["https://orcid.org/0000-0001-5670-7169"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Silvia Vicenzi","raw_affiliation_strings":["1UNIVERSITY CALIFORNIA, SAN DIEGO, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNIVERSITY CALIFORNIA, SAN DIEGO, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077105911","display_name":"Trung The Tran","orcid":"https://orcid.org/0000-0001-9496-5003","observed_orcids":["https://orcid.org/0000-0001-9496-5003"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trung Tran","raw_affiliation_strings":["2UNIVERSITY CALIFORNIA, SAN DIEGO, SAN DIEGO, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UNIVERSITY CALIFORNIA, SAN DIEGO, SAN DIEGO, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006252364","display_name":"Lara C. Avsharian","orcid":"https://orcid.org/0009-0005-7287-8650","observed_orcids":["https://orcid.org/0009-0005-7287-8650"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lara Avsharian","raw_affiliation_strings":["3University of California, San Diego, San Diego"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of California, San Diego, San Diego","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022470464","display_name":"Joshua Hartman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua Hartman","raw_affiliation_strings":["4university california, san diego, san diego","university california, san diego, san diego"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4university california, san diego, san diego","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"university california, san diego, san diego","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anna Rapp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Rapp","raw_affiliation_strings":["4university california, san diego, san diego","university california, san diego, san diego"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4university california, san diego, san diego","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"university california, san diego, san diego","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016355760","display_name":"Leslie\u00a0A. Crews","orcid":"https://orcid.org/0000-0003-0704-0067","observed_orcids":["https://orcid.org/0000-0003-0704-0067"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Crews","raw_affiliation_strings":["5Division of Regenerative Medicine, Department of Medicine, and Sanford Stem Cell Institute, UCSD, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Division of Regenerative Medicine, Department of Medicine, and Sanford Stem Cell Institute, UCSD, La Jolla, CA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"142","issue":"Supplement 1","first_page":"6604","last_page":"6604"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.09220000356435776,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9350000023841858},{"id":"https://openalex.org/keywords/irf4","display_name":"IRF4","score":0.9190000295639038},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.871999979019165},{"id":"https://openalex.org/keywords/macrophage-polarization","display_name":"macrophage polarization","score":0.9819999933242798},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.7200000286102295},{"id":"https://openalex.org/keywords/m1-macrophages","display_name":"M1 macrophages","score":0.8889999985694885},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.7820000052452087},{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.6259999871253967},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8410000205039978},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.5180000066757202},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.382999986410141},{"id":"https://openalex.org/keywords/il-23","display_name":"IL-23","score":0.593999981880188},{"id":"https://openalex.org/keywords/il-27","display_name":"IL-27","score":0.5659999847412109},{"id":"https://openalex.org/keywords/il-28","display_name":"IL-28","score":0.4650000035762787},{"id":"https://openalex.org/keywords/il-29","display_name":"IL-29","score":0.6819999814033508},{"id":"https://openalex.org/keywords/il-33","display_name":"IL-33","score":0.460999995470047},{"id":"https://openalex.org/keywords/il-36","display_name":"IL-36","score":0.5299999713897705},{"id":"https://openalex.org/keywords/il-37","display_name":"IL-37","score":0.6430000066757202},{"id":"https://openalex.org/keywords/il-38","display_name":"IL-38","score":0.7179999947547913},{"id":"https://openalex.org/keywords/il-40","display_name":"IL-40","score":0.5490000247955322}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.793199360370636},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5869175791740417},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5382772088050842},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5159738659858704},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.5096251964569092},{"id":"https://openalex.org/C2776682551","wikidata":"https://www.wikidata.org/wiki/Q21072584","display_name":"Macrophage polarization","level":4,"score":0.5053958892822266},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45372700691223145},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.4313986897468567},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.4136267900466919},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.3179352283477783},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30445289611816406},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2023-187814","doi":"https://doi.org/10.1182/blood-2023-187814","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2023-187814","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7020144177","https://openalex.org/W7206212669","https://openalex.org/W2519269392","https://openalex.org/W3134646800","https://openalex.org/W6922171588","https://openalex.org/W4223930219","https://openalex.org/W4382023394","https://openalex.org/W2586488855","https://openalex.org/W3119873108","https://openalex.org/W2092722989"],"abstract_inverted_index":{"The":[0],"tumor":[1],"microenvironment":[2,73,239],"(TME)":[3],"has":[4,181,240],"emerged":[5],"as":[6,17,19,273,344,346],"a":[7,90,153,158,177,274,304,415,457,486,495],"key":[8,458],"contributor":[9],"to":[10,122,129,134,140,185,213,220,250,268,317,363,395,440,444],"cancer":[11,94],"progression":[12,98,188],"in":[13,24,93,103,138,236,257,351,356,383,407,430,461],"numerous":[14],"solid":[15],"tumors":[16],"well":[18,345],"blood":[20],"cancers":[21],"that":[22,67,180,402,418,454,479],"evolve":[23],"the":[25,30,46,63,70,82,146,218,228,237,253,262,292,319,338,361,411],"bone":[26],"marrow":[27],"(BM).":[28],"In":[29,162,245],"context":[31],"of":[32,37,52,65,148,192,210,234,255,264,307,324,340,349,390,405,497],"multiple":[33],"myeloma":[34],"(MM),":[35],"survival":[36,96,191],"malignant":[38,193],"plasma":[39,194],"cells":[40],"is":[41,50,74,176,485],"supported":[42],"by":[43,108,501],"interactions":[44],"with":[45,120,314,386,492],"BM":[47,72,83],"microenvironment,":[48],"which":[49,126,221,364],"comprised":[51],"various":[53],"components":[54],"including":[55],"cells,":[56],"extracellular":[57],"matrix,":[58],"and":[59,97,99,132,165,231,260,291,299,311,328,330,334,354,373,376,449,477,494],"soluble":[60],"factors.":[61],"Therefore,":[62],"development":[64],"strategies":[66],"specifically":[68],"target":[69],"MM":[71,187,238,321,493],"crucial":[75],"for":[76,472,490],"improving":[77],"current":[78],"disease":[79,169],"prognosis.":[80],"Within":[81],"niche,":[84],"M2-like":[85,214,352,408,426,447],"myeloma-associated":[86,270],"macrophages":[87,211,235,271,380,409,448],"(MAMs)":[88,272],"play":[89],"significant":[91],"role":[92,254,460],"cell":[95,295],"have":[100],"been":[101,183,242],"implicated":[102],"producing":[104],"an":[105,480,502],"immune-suppressive":[106],"TME":[107],"generating":[109],"inflammatory":[110,164],"mediators,":[111],"growth":[112,309],"factors,":[113],"cytokines,":[114,312],"chemokines,":[115],"etc.":[116],"Macrophages":[117],"exhibit":[118],"plasticity":[119],"regard":[121],"their":[123],"polarization":[124,229,259,283,301,372,412,431],"state,":[125],"enable":[127],"them":[128],"dynamically":[130],"respond":[131],"adapt":[133],"different":[135],"environmental":[136],"stimuli":[137],"order":[139],"fulfill":[141],"important":[142],"immune":[143],"functions.":[144],"Thus,":[145],"reprogramming":[147,483],"M2-like,":[149],"pro-tumoral":[150,232],"MAMs":[151,476],"toward":[152,414],"M1-like,":[154],"anti-tumoral":[155],"phenotype":[156,417],"represents":[157],"promising":[159,487],"therapeutic":[160,276,488],"strategy.":[161,277],"MM,":[163],"anti-viral":[166],"pathways":[167],"promote":[168,186],"progression.":[170],"Interferon":[171],"regulatory":[172,459],"factor":[173,179],"4":[174],"(IRF4)":[175],"transcription":[178],"previously":[182],"shown":[184],"through":[189],"enhanced":[190,420],"cells.":[195],"Under":[196],"physiological":[197],"conditions,":[198],"IRF4":[199,222,256,266,350,365,406,442,451,455],"also":[200],"regulates":[201],"macrophage":[202,258,282,342,371,463,482],"polarization,":[203],"where":[204],"its":[205],"expression":[206,267,348,399],"drives":[207],"alternative":[208],"activation":[209,223,366],"primarily":[212],"(anti-inflammatory)":[215],"phenotypes.":[216],"However,":[217],"extent":[219,362],"or":[224,367],"direct":[225,368],"inhibition":[226,369],"governs":[227,370],"status":[230,413],"activity":[233],"not":[241],"fully":[243],"elucidated.":[244],"this":[246],"study,":[247],"we":[248,279],"sought":[249],"further":[251,434],"explore":[252],"investigated":[261],"potential":[263],"modulating":[265],"reprogram":[269],"novel":[275],"First,":[278],"developed":[280],"myeloma-tailored":[281],"models":[284,302],"using":[285],"primary":[286],"human":[287],"peripheral":[288],"blood-derived":[289],"monocytes":[290,393,437],"THP1":[293,392],"monocyte":[294],"line.":[296],"Our":[297],"M1":[298,325],"M2":[300,331],"utilize":[303],"customized":[305],"cocktail":[306],"myeloid":[308],"factors":[310],"supplemented":[313],"interleukin":[315],"(IL)-6":[316],"mimic":[318],"IL-6-enriched":[320],"microenvironment.":[322],"Characterization":[323],"(CD80,":[326],"TNF\u03b1,":[327],"CXCL10)":[329],"(MRC1,":[332],"FN1,":[333],"CCL22)":[335],"markers":[336],"confirmed":[337],"presence":[339],"distinct":[341],"subpopulations,":[343],"upregulated":[347],"progeny":[353],"IRF5":[355],"M1-like":[357,421],"macrophages.":[358],"To":[359],"investigate":[360],"function,":[374],"overexpression":[375],"knockdown":[377],"experiments":[378],"on":[379,475],"were":[381,438],"performed":[382],"vitro,":[384],"along":[385],"whole":[387],"transcriptome":[388],"sequencing":[389],"IRF4-overexpressing":[391],"compared":[394],"vector-transduced":[396],"controls.":[397],"Gene":[398],"analyses":[400],"revealed":[401],"genetic":[403],"down-modulation":[404],"shifts":[410],"hybrid":[416],"displays":[419],"properties,":[422],"while":[423],"still":[424],"retaining":[425],"characteristics.":[427],"This":[428],"shift":[429],"state":[432],"was":[433],"amplified":[435],"when":[436],"transduced":[439],"overexpress":[441],"prior":[443],"differentiation":[445],"into":[446],"subsequent":[450],"knockdown,":[452],"suggesting":[453],"plays":[456],"tuning":[462],"polarization.":[464],"Taken":[465],"together,":[466],"our":[467],"preclinical":[468],"findings":[469],"provide":[470],"groundwork":[471],"future":[473],"studies":[474],"suggest":[478],"IRF4-mediated":[481],"strategy":[484],"approach":[489],"patients":[491],"variety":[496],"other":[498],"malignancies":[499],"typified":[500],"anti-inflammatory":[503],"TME.":[504]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-12-02T00:00:00"}